Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
E. De Freitas Gonzalez (León, Spain), J. Juan García (León, Spain), R. Almeida Cabrera (León, Spain), C. Mier Bango (León, Spain), C. López Garay (León, Spain), E. Bollo De Miguel (León, Spain), I. Herráez Ortega (León, Spain), N. Alonso Orcajo (León, Spain), L. Sierra Herranz (León, Spain). Gender perspective in Interstitial Lung Diseases (ILD). 1413

Member's Comments

No comment yet.

Related content which might interest you: The incidence of Progressive Fibrotic Interstitial Lung Diseases (PFILD) treatable with oral-antifibrotic therapy in a UK Specialist Interstitial Lung Disease clinic. Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020 Unclassifiable Interstitial Lung Disease (ILD). Why? Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 Combined pulmonary fibrosis and emphysema: A report from the Hellenic Interstitial Lung Diseases group Source: Annual Congress 2010 - Different patterns of interstitial lung disease Year: 2010 Analysis of children’s diffuse parenchymal lung disease from the European Management Platform for Childhood Interstitial Lung Diseases: Frequency of disease categories and treatments used Source: International Congress 2017 – Rare diseases Year: 2017 Usefulness of electronic nose in detection of Interstitial Lung Diseases (ILD) Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia Year: 2019 Evaluation of three dyspnea questionnaires in the progression of Interstitial Lung Diseases. Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 Autoantibodies in Interstitial Lung Diseases Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia Year: 2021 Hypersentivity pneumonitis in an Interstitial Lung Disease Unit, 5 years’ experience Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause Year: 2020 Role of Pulmonary Rehabilitation (PR) on clinical care in patients with advance Interstitial Lung Diseases. Does it make any difference? Source: Virtual Congress 2021 – New approaches to pulmonary rehabilitation and chronic care Year: 2021 Romanian Registry for Interstitial Lung Diseases (REGIS): inclusion of patients in 3 years Source: International Congress 2017 – ILDs: clinical problems Year: 2017 Inmunosuppresor therapy effectivness in Interstitial Lung Disease (ILD) associated Connective Tisuue Disease(CTD). Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 GPs Meet Rare Lung Disorders Task Force factsheet: childhood interstitial lung disease Source: Breathe 2014; 10:173-175 Year: 2014 Impact of a Bayesian approach on the diagnosis of Interstitial Lung Diseases Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019 Value of community based Pulmonary Rehabilitation (PR) for patients with Interstitial Lung Disease (ILD): A retrospective review Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019 Predictive Findings of Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Telomere length in fibrotic groups of Interstitial Lung Diseases Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF) Year: 2018 Interstitial Lung Disease (ILD) in aluminium welders Source: Virtual Congress 2020 – Occupational and environmental causes of respiratory disease Year: 2020 Radiation pneumonitis; early diagnosis and associated factors Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014